Bowhead Specialty Holdings Inc. reported Q1 2026 results with gross written premiums up 24% to $216.7 million, net income of $16.0 million or $0.48 per diluted share, alongside reinsurance agreement amendments and annual stockholder meeting results.
Key takeaways
Gross written premiums increased 24.0% to $216.7 million, driven by Casualty (20.4%) and Baleen Specialty (313.9%) growth.
Net income $16.0 million ($0.48 diluted EPS), combined ratio improved to 95.3% from 97.3%.
Quota Share Reinsurance Agreement amended to raise AFMIC termination GWP threshold to $1.5 billion from $1.0 billion, extend notice to 365 days.
Ceding fee increases phased in, reaching 5.75% for GWP over $1.0 billion in 2027.
Stockholders elected four Class II directors and ratified PricewaterhouseCoopers LLP as auditors.
Net investment income rose 43.5% to $18.0 million on higher investment balances.